# Safety and Immunogenicity of a New Serum-free DTaP-IPVvero Combination Vaccine

> **NCT00655148** · PHASE3 · COMPLETED · sponsor: **Statens Serum Institut** · enrollment: 817 (actual)

## Conditions studied

- Active Immunization

## Interventions

- **BIOLOGICAL:** DTaP-IPV vero vaccine
- **BIOLOGICAL:** DTaP-IPV mkc vaccine

## Key facts

- **NCT ID:** NCT00655148
- **Lead sponsor:** Statens Serum Institut
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-09
- **Primary completion:** 2006-10
- **Final completion:** 2006-10
- **Target enrollment:** 817 (ACTUAL)
- **Last updated:** 2013-01-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00655148

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00655148, "Safety and Immunogenicity of a New Serum-free DTaP-IPVvero Combination Vaccine". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00655148. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*